Benzeno Sharon
- SEC CIK
- 0001780854
In the past year, 4 open-market sale filings worth $14.7M and no purchases.
Current role at each company
- ADPT Adaptive Biotechnologies CorpChief Commercial Ofc Imm Medas of Jun 30, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $14.7M
- 4 filings
- Net
- −$14.7M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Benzeno Sharon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 (view filing) | Jun 26-29 | 4 days | Benzeno SharonChief Commercial Ofc Imm Med | SSale | −165.8K | $21.13 | −$3.50M | −42.8%221.3K after | 2 lots10b5-1 |
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | Benzeno SharonChief Commercial Ofc Imm Med | SSale | −63.1K | $13.17 | −$831.1K | −18.8%272.8K after | |
| Dec 8, 2025 (view filing) | Dec 4 | 4 days | Benzeno SharonChief Commercial Ofc Imm Med | SSale | −12.6K | $16.85 | −$212.4K | −4.1%296.8K after | 10b5-1 |
| Nov 24, 2025 (view filing) | Nov 20-21 | 4 days | Benzeno SharonChief Commercial Ofc Imm Med | SSale | −606.4K | $16.73 | −$10.1M | −67.1%296.8K after | 2 lots10b5-1 |
| Mar 6, 2025 (view filing) | Mar 5 | 1 day | Benzeno SharonChief Commercial Ofc Imm Med | SSale | −44.7K | $6.98 | −$311.8K | −10.2%392.7K after | 2 lots |
| Mar 6, 2024 (view filing) | Mar 5 | 1 day | Benzeno SharonChief Commercial Ofc Imm Med | SSale | −29.4K | $3.44 | −$101.0K | −8.2%327.4K after | 2 lots |
| Mar 8, 2023 (view filing) | Mar 6 | 2 days | Benzeno SharonChief Commercial Ofc Imm Med | SSale | −11.7K | $8.57 | −$100.7K | −5.0%223.8K after | |
| Mar 8, 2022 (view filing) | Mar 7 | 1 day | Benzeno SharonChief Business Development Off | SSale | −2.67K | $12.01 | −$32.1K | −2.5%102.6K after |